☆ 4.7 Review

Nanoparticle-Based Treatment in Glioblastoma

JOURNAL OF PERSONALIZED MEDICINE (2023)

Related references

Note: Only part of the references are listed.

Article Biochemical Research Methods

The comparison of biodistribution of glutathione PEGylated nanoliposomal doxorubicin formulations prepared by pre-insertion and post-insertion methods for brain delivery in normal mice

Amin Mehrabian et al.

Summary: Several obstacles limit the efficacy of brain tumour treatment, most notably the blood-brain barrier, which prevents the brain uptake of the majority of accessible medicines due to tight junctions. The presence of glutathione receptors on the BBB surface has been demonstrated in numerous papers; consequently, products containing glutathione as a targeting ligand coupled with nanoliposomes are used to enhance drug delivery across the BBB.

IET NANOBIOTECHNOLOGY (2023)

Add to Collection

Article Multidisciplinary Sciences

CAR-neutrophil mediated delivery of tumor-microenvironment responsive nanodrugs for glioblastoma chemo-immunotherapy

Yun Chang et al.

Summary: This study demonstrates the efficacy of neutrophil-mediated drug delivery for brain tumor treatment using CAR-modified neutrophils and chemodrug-loaded nanoparticles. The approach shows promising results in preclinical glioblastoma models and addresses the issue of blood-brain barrier restrictions.

NATURE COMMUNICATIONS (2023)

Add to Collection

Article Multidisciplinary Sciences

STING agonist-loaded, CD47/PD-L1-targeting nanoparticles potentiate antitumor immunity and radiotherapy for glioblastoma

Peng Zhang et al.

Summary: The study describes the use of a bridging-lipid nanoparticle (B-LNP) that engages tumor-associated myeloid cells (TAMCs) to glioblastoma cells via anti-CD47/PD-L1 dual ligation. The B-LNPs block CD47 and PD-L1, promote TAMC phagocytic activity, and enhance T cell recruitment and antitumor responses. The administration of B-LNP/diABZI combined with radiotherapy promotes brain tumor regression and induces immunological memory against glioma.

NATURE COMMUNICATIONS (2023)

Add to Collection

Article Engineering, Biomedical

Core-shell lipoplexes inducing active macropinocytosis promote intranasal delivery of c-Myc siRNA for treatment of glioblastoma

Yang Hu et al.

Summary: In this study, a lipoplex was designed to address the unmet demands on intranasal siRNA delivery to the brain for treatment of glioma. The lipoplex exhibited a stable core-shell structure and could be selectively internalized along with cell debris by glioma cells via active macropinocytosis. This lipoplex improved the gene delivery efficiency of intranasal administration and was promising in the perspective of selectively silencing disease-related genes in intracranial tumor.

ACTA BIOMATERIALIA (2022)

Add to Collection

Article Oncology

Targeting immunoliposomes to EGFR-positive glioblastoma

B. Kasenda et al.

Summary: This study evaluated the tolerability and effectiveness of anti-EGFR immunoliposomes in treating patients with relapsed glioblastoma harboring an EGFR amplification. The results showed that these immunoliposomes were unable to cross the blood-brain barrier, but could deliver drugs to glioblastoma tissue. In terms of efficacy, the median progression-free survival was 1.5 months and the median overall survival was 8 months.

ESMO OPEN (2022)

Add to Collection

Article Chemistry, Multidisciplinary

Systemic Delivery of an Adjuvant CXCR4-CXCL12 Signaling Inhibitor Encapsulated in Synthetic Protein Nanoparticles for Glioma Immunotherapy

Mahmoud S. Alghamri et al.

Summary: Glioblastoma (GBM) is an aggressive brain cancer with low survival rate. A study found that targeting the CXCL2/CXCR4 pathway with synthetic protein nanoparticles (SPNPs) can inhibit tumor growth and enhance immune response, improving therapeutic efficacy.

ACS NANO (2022)

Add to Collection

Review Medicine, Research & Experimental

Biomedical applications of metallic nanoparticles in cancer: Current status and future perspectives

Rubiya Khursheed et al.

Summary: The advancements in nanotechnology have led to extensive exploration of metallic nanoparticles for biomedical applications. These nanoparticles possess inert nature and nanoscale structures similar to biological molecules, and their characteristics can be altered by changing certain particle properties. They have found applications in targeted drug delivery, sensing, photothermal and photodynamic therapy, imaging, and modulation of multiple applications in biomedicine.

BIOMEDICINE & PHARMACOTHERAPY (2022)

Add to Collection

Review Neurosciences

Contemporary RNA Therapeutics for Glioblastoma

Kaitlyn Melnick et al.

Summary: RNA-based immunotherapies show potential for treating malignant brain tumors like GBM, but biological instability is a challenge. RNA-pulsed dendritic cell vaccines have been proven safe in clinical trials, while RNA-loaded nanoparticle vaccines are soon to be used in GBM patients.

NEUROMOLECULAR MEDICINE (2022)

Add to Collection

Review Chemistry, Multidisciplinary

Nanoparticles in Drug Delivery: From History to Therapeutic Applications

Obaid Afzal et al.

Summary: Current research explores the use of engineered nanoparticles in drug delivery systems, presenting various nanocarriers like polymeric nanoparticles, mesoporous nanoparticles, and nanomaterials. Nanomedicine has made significant advancements, improving drug absorption and release time for targeted treatment.

NANOMATERIALS (2022)

Add to Collection

Article Chemistry, Multidisciplinary

Optimization of Tumor Targeting Gold Nanoparticles for Glioblastoma Applications

Nicholas C. Allen et al.

Summary: Glioblastoma brain tumors are highly aggressive and invasive, with a complex tumor microenvironment that limits the effectiveness of current treatment options. This study presents a novel gold nanoparticle therapy specifically designed for glioblastoma, showing strong anti-tumor activity. The optimized design of these nanotherapies resulted in significant inhibition of tumor activity and impact on cellular morphology, providing a promising foundation for future multi-targeted approaches.

NANOMATERIALS (2022)

Add to Collection

Review Nanoscience & Nanotechnology

Nanoscale Drug Delivery Systems in Glioblastoma

Zihao Liu et al.

Summary: This review illustrates the applications of nanoparticle drug delivery systems in glioblastoma (GBM) treatment. Various nanomaterials are constructed as carriers to precisely deliver molecules with potential therapeutic effect. However, different nanoparticles have their own advantages and disadvantages.

NANOSCALE RESEARCH LETTERS (2022)

Add to Collection

Article Biochemistry & Molecular Biology

Angiopep-2 modi fi ed lipid-coated mesoporous silica nanoparticles for glioma targeting therapy overcoming BBB

Jingjing Zhu et al.

Summary: This study developed a novel nanomedicine for treating glioma, which achieved better drug targeting effect and showed significant improvement in treatment efficacy and survival time in animal experiments.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2021)

Add to Collection

Article Biophysics

Brain-targeted, drug-loaded solid lipid nanoparticles against glioblastoma cells in culture

Guliz Ak et al.

Summary: The study demonstrates that BCNU and TMZ loaded SLNs can serve as an effective anticancer system for targeted GBM therapy, showing significant antitumor activity and inducing apoptosis on cancer cells, as well as being more readily taken up by MCT-1 expressing brain cells.

COLLOIDS AND SURFACES B-BIOINTERFACES (2021)

Add to Collection

Review Biotechnology & Applied Microbiology

Nanogold-based materials in medicine: from their origins to their future

Tania Ferreira-Goncalves et al.

Summary: The properties of gold nanoparticles (AuNPs) depend on the production method used, and these distinct properties have potential applications in biomedicine for diagnostic and therapeutic approaches. Multiple production methods for AuNPs have been explored, leading to their usefulness in various biomedical applications.

NANOMEDICINE (2021)

Add to Collection

Article Chemistry, Multidisciplinary

Multifunctional ginsenoside Rg3-based liposomes for glioma targeting therapy

Ying Zhu et al.

Summary: The study found that using a liposomal system based on ginsenoside Rg3 can effectively improve the targeting of brain tumors, enhance the delivery of drugs, and play a beneficial role in anti-tumor treatment.

JOURNAL OF CONTROLLED RELEASE (2021)

Add to Collection

Article Cell Biology

A first-in-human phase 0 clinical study of RNA interference-based spherical nucleic acids in patients with recurrent glioblastoma

Priya Kumthekar et al.

Summary: The research team has developed a novel treatment approach for GBM using SNAs for precision medicine treatment, which has shown potential in clinical trials.

SCIENCE TRANSLATIONAL MEDICINE (2021)

Add to Collection

Article Polymer Science

Development of Polymer-Based Nanoformulations for Glioblastoma Brain Cancer Therapy and Diagnosis: An Update

Bijuli Rabha et al.

Summary: Brain cancers, particularly high-grade gliomas/glioblastoma, have poor prognosis despite conventional treatments due to issues like the blood-brain barrier. Nanotheranostics, combining imaging and therapies, can improve treatment efficacy, while polymer nanoparticles are gaining attention for their precise targeting and minimal adverse effects in drug delivery.

POLYMERS (2021)

Add to Collection

Review Immunology

Recent Advances in the Use of Lipid-Based Nanoparticles Against Glioblastoma Multiforme

Benita Ortega-Berlanga et al.

Summary: Glioblastoma (GBM) is a common and aggressive malignant brain tumor in adults, with challenges in treatment due to tumor location complexity and biological heterogeneity. Lipid-based nanoparticles, such as liposomes, are promising materials for delivering antitumor drugs to the central nervous system and improving therapeutic efficiency.

ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Enhanced Anticancer Response of Curcumin- and Piperine-Loaded Lignin-g-p (NIPAM-co-DMAEMA) Gold Nanogels against U-251 MG Glioblastoma Multiforme

Bilal Javed et al.

Summary: The study synthesized Lignin-g-p (NIPAM-co-DMAEMA) gold nanogel loaded with curcumin and piperine to treat GBM, which exhibited enhanced anticancer properties, improved drug toxicity and release, and induced apoptosis through endocytic pathways. The experimental evidence suggests that the combinatorial curcumin-piperine gold nanogels have the potential to overcome the limitations of conventional chemotherapeutic treatments for glioma cells.

BIOMEDICINES (2021)

Add to Collection

Article Chemistry, Multidisciplinary

Potential Use of Nitrogen-Doped Carbon Nanotube Sponges as Payload Carriers Against Malignant Glioma

Aleli Salazar et al.

Summary: Nitrogen-doped carbon nanotube sponges (N-CNSs) are a new type of nanomaterial with high biocompatibility that can load large amounts of hydrophobic drugs, making them suitable carriers for chemotherapeutic agents. The study showed that N-CNSs can continuously release carmustine without inducing cytotoxicity, making them promising candidates for targeted drug delivery in malignant gliomas.

NANOMATERIALS (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Angiopep-2-Modified Carboxymethyl Chitosan-Based pH/Reduction Dual-Stimuli-Responsive Nanogels for Enhanced Targeting Glioblastoma

Panpan Song et al.

Summary: A pH/reduction-sensitive carboxymethyl chitosan nanogel modified by targeting peptide angiopep-2 loaded with doxorubicin shows promising potential for targeted chemotherapy of glioblastoma. The targeted nanogel exhibited good stability, biocompatibility, and enhanced BBB penetration and tumor targeting ability, leading to higher drug uptake and stronger antitumor activity compared to nontargeted nanogels. This innovative nanogel platform with pH/reduction dual-stimuli response may hold great significance for GBM-targeted therapy.

BIOMACROMOLECULES (2021)

Add to Collection

Review Biochemistry & Molecular Biology

Novel Strategies for Nanoparticle-Based Radiosensitization in Glioblastoma

Henry Ruiz-Garcia et al.

Summary: Nanomedicine plays a crucial role in the treatment of GBM, with nanoparticles showing promise as radiosensitizers for improved therapeutic outcomes. Researchers are actively exploring novel treatment strategies, such as combining preoperative radiation with nanoradiosensitizers.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Add to Collection

Review Oncology

Uncovering Spatiotemporal Heterogeneity of High-Grade Gliomas: From Disease Biology to Therapeutic Implications

Andrea Comba et al.

Summary: Glioblastomas are the most common and aggressive tumors of the central nervous system, characterized by heterogeneity at histological, cellular, genomic, and dynamic levels. This heterogeneity is suggested to arise from organized and dynamic attributes, favoring malignancy and influencing treatment regimens.

FRONTIERS IN ONCOLOGY (2021)

Add to Collection

Review Health Care Sciences & Services

The Enhanced Permeability and Retention (EPR) Effect: The Significance of the Concept and Methods to Enhance Its Application

Jun Wu

Summary: Chemotherapy for human solid tumors faces challenges in delivering anticancer compounds selectively into tumor tissues to maintain effective concentration levels for a certain duration, hindering the execution of anticancer activities. Targeting therapy via the enhanced permeability and retention effect may not always be successful, as it depends on tumor type, location, blood perfusion status, and properties of macromolecular anticancer agents. Efforts to maximize the EPR effect in developing smarter nanomedicines are essential for successful clinical applications.

JOURNAL OF PERSONALIZED MEDICINE (2021)

Add to Collection

Article Chemistry, Physical

Immunostimulatory silica nanoparticle boosts innate immunity in brain tumors

Peter A. Bielecki et al.

Summary: The study focused on using an immunostimulatory mesoporous silica nanoparticle, termed immuno-MSN, to boost the local innate immune compartment of GBM and enhance the antitumor immune response, resulting in elevated pro-inflammatory effects.

NANOSCALE HORIZONS (2021)

Add to Collection

Review Oncology

Nano-Therapies for Glioblastoma Treatment

Edouard Alphandery

CANCERS (2020)

Add to Collection

Article Pharmacology & Pharmacy

Glioblastoma chemotherapeutic agents used in the clinical setting and in clinical trials: Nanomedicine approaches to improve their efficacy

Juan Aparicio-Blanco et al.

INTERNATIONAL JOURNAL OF PHARMACEUTICS (2020)

Add to Collection

Review Oncology

Management of glioblastoma: State of the art and future directions

Aaron C. Tan et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2020)

Add to Collection

Article Pharmacology & Pharmacy

Advancement in nanogel formulations provides controlled drug release

Shayan Ahmed et al.

INTERNATIONAL JOURNAL OF PHARMACEUTICS (2020)

Add to Collection

Article Medicine, Research & Experimental

HDAC inhibitors elicit metabolic reprogramming by targeting super-enhancers in glioblastoma models

Trang Thi Thu Nguyen et al.

JOURNAL OF CLINICAL INVESTIGATION (2020)

Add to Collection

Review Pharmacology & Pharmacy

Gold Nanoparticles in Glioma Theranostics

Mohammad Norouzi

PHARMACOLOGICAL RESEARCH (2020)

Add to Collection

Review Pharmacology & Pharmacy

Carbon nanostructures: The drug and the delivery system for brain disorders

T. K. Henna et al.

INTERNATIONAL JOURNAL OF PHARMACEUTICS (2020)

Add to Collection

Article Multidisciplinary Sciences

Systemic brain tumor delivery of synthetic protein nanoparticles for glioblastoma therapy

Jason V. Gregory et al.

NATURE COMMUNICATIONS (2020)

Add to Collection

Review Oncology

Potential for Treatment of Glioblastoma: New Aspects of Superparamagnetic Iron Oxide Nanoparticles

Dana Marekova et al.

ANTICANCER RESEARCH (2020)

Add to Collection

Review Biochemistry & Molecular Biology

Solid Lipid Nanoparticles for Drug Delivery: Pharmacological and Biopharmaceutical Aspects

Sebastian Scioli Montoto et al.

FRONTIERS IN MOLECULAR BIOSCIENCES (2020)

Add to Collection

Review Medicine, Research & Experimental

Nanocarrier-based drug combination therapy for glioblastoma

Mengnan Zhao et al.

THERANOSTICS (2020)

Add to Collection

Review Nanoscience & Nanotechnology

Lipid-polymer hybrid nanoparticles as a next-generation drug delivery platform: state of the art, emerging technologies, and perspectives

Anubhab Mukherjee et al.

INTERNATIONAL JOURNAL OF NANOMEDICINE (2019)

Add to Collection

Article Neurosciences

Visualization of spatiotemporal dynamics of human glioma stem cell invasion

Ryota Tamura et al.

MOLECULAR BRAIN (2019)

Add to Collection

Article Engineering, Biomedical

Cancer-selective nanoparticles for combinatorial siRNA delivery to primary human GBM in vitro and in vivo

Kristen L. Kozielski et al.

BIOMATERIALS (2019)

Add to Collection

Article Oncology

A tumor-targeting nanomedicine carrying the p53 gene crosses the blood-brain barrier and enhances anti-PD-1 immunotherapy in mouse models of glioblastoma

Sang-Soo Kim et al.

INTERNATIONAL JOURNAL OF CANCER (2019)

Add to Collection

Review Toxicology

Oxidative stress injury in doxorubicin-induced cardiotoxicity

Mei Songbo et al.

TOXICOLOGY LETTERS (2019)

Add to Collection

Article Medicine, Research & Experimental

Effect of Surface Charges on Oral Absorption of Intact Solid Lipid Nanoparticles

Zhou Yu et al.

MOLECULAR PHARMACEUTICS (2019)

Add to Collection

Review Pharmacology & Pharmacy

Approaches to physical stimulation of metallic nanoparticles for glioblastoma treatment

Sophie Pinel et al.

ADVANCED DRUG DELIVERY REVIEWS (2019)

Add to Collection

Review Medicine, Research & Experimental

Mesoporous silica nanoparticles for therapeutic/diagnostic applications

Samira Jafari et al.

BIOMEDICINE & PHARMACOTHERAPY (2019)

Add to Collection

Article Oncology

How to analyse the spatiotemporal tumour samples needed to investigate cancer evolution: A case study using paired primary and recurrent glioblastoma

Alastair Droop et al.

INTERNATIONAL JOURNAL OF CANCER (2018)

Add to Collection

Article Nanoscience & Nanotechnology

Enhancing glioblastoma treatment using cisplatin-gold-nanoparticle conjugates and targeted delivery with magnetic resonance-guided focused ultrasound

Daniel Coluccia et al.

NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2018)

Add to Collection

Review Pharmacology & Pharmacy

Current Challenges and Opportunities in Treating Glioblastoma

Andrea Shergalis et al.

PHARMACOLOGICAL REVIEWS (2018)

Add to Collection

Article Chemistry, Multidisciplinary

Cell-permeable NF-κB inhibitor-conjugated liposomes for treatment of glioma

Yanyu Zhang et al.

JOURNAL OF CONTROLLED RELEASE (2018)

Add to Collection

Article Medicine, General & Internal

Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma A Randomized Clinical Trial

Roger Stupp et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)

Add to Collection

Article Chemistry, Multidisciplinary

Tailored theranostic apolipoprotein E3 porphyrin-lipid nanoparticles target glioblastoma

M. A. Rajora et al.

CHEMICAL SCIENCE (2017)

Add to Collection

Article Oncology

A phase 1 trial of intravenous liposomal irinotecan in patients with recurrent high-grade glioma

Jennifer L. Clarke et al.

CANCER CHEMOTHERAPY AND PHARMACOLOGY (2017)

Add to Collection

Review Oncology

Therapeutic options in recurrent glioblastoma-An update

Katharina Seystahl et al.

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2016)

Add to Collection

Review Pharmacology & Pharmacy

Interactions between carbon nanotubes and bioactives: a drug delivery perspective

Neelesh Kumar Mehra et al.

DRUG DISCOVERY TODAY (2016)

Add to Collection

Review Chemistry, Multidisciplinary

Nanoparticle-mediated brain drug delivery: Overcoming blood-brain barrier to treat neurodegenerative diseases

Claudia Saraiva et al.

JOURNAL OF CONTROLLED RELEASE (2016)

Add to Collection

Review Materials Science, Biomaterials

New progress and prospects: The application of nanogel in drug delivery

Hui Zhang et al.

MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS (2016)

Add to Collection

Review Chemistry, Multidisciplinary

Nanoparticles for Targeting Intratumoral Hypoxia: Exploiting a Potential Weakness of Glioblastoma

Mihaela Aldea et al.

PHARMACEUTICAL RESEARCH (2016)

Add to Collection

Article Nanoscience & Nanotechnology

Arginine-Glycine-Aspartic Acid-Modified Lipid-Polymer Hybrid Nanoparticles for Docetaxel Delivery in Glioblastoma Multiforme

Kairong Shi et al.

JOURNAL OF BIOMEDICAL NANOTECHNOLOGY (2015)

Add to Collection

Review Chemistry, Multidisciplinary

Controlled drug delivery systems: Past forward and future back

Kinam Park

JOURNAL OF CONTROLLED RELEASE (2014)

Add to Collection

Article Medicine, Research & Experimental

Mechanism Study of Cellular Uptake and Tight Junction Opening Mediated by Goblet Cell-Specific Trimethyl Chitosan Nanoparticles

Jian Zhang et al.

MOLECULAR PHARMACEUTICS (2014)

Add to Collection

Article Engineering, Biomedical

Multiwalled Carbon Nanotubes Hinder Microglia Function Interfering with Cell Migration and Phagocytosis

Juan C. Villegas et al.

ADVANCED HEALTHCARE MATERIALS (2014)

Add to Collection

Article Chemistry, Multidisciplinary

Hollow superparamagnetic iron oxide nanoshells as a hydrophobic anticancer drug carrier: intracelluar pH-dependent drug release and enhanced cytotoxicity

Xiao-Ming Zhu et al.

NANOSCALE (2012)

Add to Collection

Review Biochemistry & Molecular Biology

Nanoparticles in cellular drug delivery

Amir H. Faraji et al.

BIOORGANIC & MEDICINAL CHEMISTRY (2009)

Add to Collection

Article Oncology

RNOP-09: Pegylated liposomal doxorubicine and prolonged temozolomide in addition to radiotherapy in newly diagnosed glioblastoma - a phase II study

Christoph P. Beier et al.

BMC CANCER (2009)

Add to Collection

Article Chemistry, Multidisciplinary

Role of Convective Flow in Carmustine Delivery to a Brain Tumor

Davis Yohanes Arifin et al.

PHARMACEUTICAL RESEARCH (2009)

Add to Collection

Review Pharmacology & Pharmacy

Blood-brain barrier delivery

William M. Pardridge

DRUG DISCOVERY TODAY (2007)

Add to Collection

Article Medicine, General & Internal

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

R Stupp et al.

NEW ENGLAND JOURNAL OF MEDICINE (2005)

Add to Collection

© Peeref 2019-2024. All rights reserved.